ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2019

Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany.

Bernadette Pöllinger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.